Altogether, our study corroborates the existing literature and adds to the knowledge base through the development of explainable machine learning models that combine circulating GDF15 levels with clinically relevant factors to accurately prognosticate limb outcomes in patients with PAD. This evidence concerns the gene GDF15 and peripheral arterial disease.